Who Attends?
What Our Speakers Are Looking Forward To:
‘’With rich experience in oligonucleotides CMC and analytical development through both internal operations and collaboration, I appreciate the Summit which offers opportunities to enhance communication among colleagues in this field.’’
Bing Guan, Associate Director, Drug Substance Development & Manufacturing, Iveric Bio
‘’General introduction on various purification techniques applicable to Oligonucleotides is great interest to many scientist and cross-functional teams. Understanding and identifying potential purification challenges could avoid costly errors.’’
Mahender Gurram, Director, Entrada Therapeutics